{"title":"化挑战为优势:多发性骨髓瘤后凸成形术的技术报告","authors":"N. Silver, Y. Barzilay","doi":"10.37421/2165-7939.2020.9.449","DOIUrl":null,"url":null,"abstract":"Kyphoplasty, a procedure first described in 2001 for the treatment of osteoporotic Vertebral Compression Fractures (VCFs) has since been used successfully for pathological vertebral compression fractures, including those caused by multiple myeloma. Whilst the evidence base for kyphoplasty remains incomplete, there is a general consensus that it is safe and significantly reduces pain in up to 84% of patients in whom nonsurgical management has failed.","PeriodicalId":89593,"journal":{"name":"Journal of spine","volume":"9 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Turning a Challenge into an Advantage: A Technical Report on Kyphoplasty for Multiple Myeloma\",\"authors\":\"N. Silver, Y. Barzilay\",\"doi\":\"10.37421/2165-7939.2020.9.449\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Kyphoplasty, a procedure first described in 2001 for the treatment of osteoporotic Vertebral Compression Fractures (VCFs) has since been used successfully for pathological vertebral compression fractures, including those caused by multiple myeloma. Whilst the evidence base for kyphoplasty remains incomplete, there is a general consensus that it is safe and significantly reduces pain in up to 84% of patients in whom nonsurgical management has failed.\",\"PeriodicalId\":89593,\"journal\":{\"name\":\"Journal of spine\",\"volume\":\"9 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of spine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37421/2165-7939.2020.9.449\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of spine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37421/2165-7939.2020.9.449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Turning a Challenge into an Advantage: A Technical Report on Kyphoplasty for Multiple Myeloma
Kyphoplasty, a procedure first described in 2001 for the treatment of osteoporotic Vertebral Compression Fractures (VCFs) has since been used successfully for pathological vertebral compression fractures, including those caused by multiple myeloma. Whilst the evidence base for kyphoplasty remains incomplete, there is a general consensus that it is safe and significantly reduces pain in up to 84% of patients in whom nonsurgical management has failed.